The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-oxo-4-(1,2,3,4-tetrahydroisoquinolin-7-ylamino)butanamido)-3-p-tolylpropanoic acid hydrochloride ID: ALA1208850
Chembl Id: CHEMBL1208850
PubChem CID: 49862018
Max Phase: Preclinical
Molecular Formula: C23H28ClN3O4
Molecular Weight: 409.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(C(CC(=O)O)NC(=O)CCC(=O)Nc2ccc3c(c2)CNCC3)cc1.Cl
Standard InChI: InChI=1S/C23H27N3O4.ClH/c1-15-2-4-17(5-3-15)20(13-23(29)30)26-22(28)9-8-21(27)25-19-7-6-16-10-11-24-14-18(16)12-19;/h2-7,12,20,24H,8-11,13-14H2,1H3,(H,25,27)(H,26,28)(H,29,30);1H
Standard InChI Key: WVNJYGNOECSHLP-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 409.49Molecular Weight (Monoisotopic): 409.2002AlogP: 2.69#Rotatable Bonds: 8Polar Surface Area: 107.53Molecular Species: ZWITTERIONHBA: 4HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.30CX Basic pKa: 8.62CX LogP: -0.41CX LogD: -0.43Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.54Np Likeness Score: -0.73
References 1. Krysko AA, Krysko OL, Kabanova TA, Andronati SA, Kabanov VM.. (2010) Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin., 20 (15): [PMID:20598885 ] [10.1016/j.bmcl.2010.06.051 ]